A61K 9 - Medicinal preparations characterised by special physical form

Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2002
12/18/2002	CN1385197A Ointment for wound healing
12/18/2002	CN1385196A Multi-function health care food and application thereof
12/18/2002	CN1385164A Sow-released roxithromycin capsule and method for preparing same
12/18/2002	CN1385163A Process for preparing novel medicine for breviscapine having function of promoting blood circulation and removing blood stasis
12/18/2002	CN1385162A Erigreron breviscapus extract controlled releasing tablet and preparation method thereof
12/18/2002	CN1385159A Doxycycline vibramycin enteric soluble preparation for treating peridentitis
12/18/2002	CN1385155A Punerarin oral capsule and oral liquid
12/18/2002	CN1385151A Slow-released dosage form of sodium ferulate and preparation process thereof
12/18/2002	CN1385149A Time-selection medicine releasing system
12/18/2002	CN1385148A Constant speed released terbutaline controlled releasing preparation
12/18/2002	CN1385147A Nano calamine and preparation method and use thereof
12/18/2002	CN1385146A Ultramicrobe emulsifier and preparation method and use thereof
12/18/2002	CN1096280C Excipient having high compactability and process for preparing same
12/18/2002	CN1096279C Foaming mixture of alkalis salt or lysine salt with acid unresolvable or difficult resolving active material
12/18/2002	CN1096274C Drug-dropping tablet and its preparing process
12/18/2002	CN1096273C Drug-dropping cigarette and its preparing process
12/18/2002	CN1096270C No scar scald treating ointment
12/18/2002	CN1096268C Tylosin containing sustained release veterinary compositions
12/18/2002	CN1096264C Stable aqueous solubilizates of carotenods and vitamins
12/18/2002	CN1096263C Lipid complexes and liposomes of highly insoluble platnium complexes
12/18/2002	CA2412888A1 Process for producing phospholipid-containing drug
12/17/2002	US6495680 A helical composition comprising a plurality of aromatic substituents linked by at least one amide group, the composition having a curved backbone due at least in part to intramolecular hydrogen bonds that rigidify the amide linkage
12/17/2002	US6495608 Methods of performing surgery with galactomannan polymers and borate
12/17/2002	US6495605 Pure isomers
12/17/2002	US6495603 Anti-inflammatory eye drop
12/17/2002	US6495598 Perfusate preparation for ophthalmic operation
12/17/2002	US6495579 Administering to a multiple sclerosis patient a therapeutically effective amount of a paclitaxel formulation contining a homo or copopolymer
12/17/2002	US6495535 Prefilled syringes or ampules for self administration containing dissolved carbon dioxide or nitrogen to retard oxidative degradation
12/17/2002	US6495534 Stabilized aqueous suspensions for parenteral use
12/17/2002	US6495527 Enhancing binding ability of a protein, such as human serum albumin; therapeutic agent carrier
12/17/2002	US6495522 Substituted alpha-hydroxy acid caspase inhibitors and the use thereof
12/17/2002	US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein
12/17/2002	US6495172 Method of using steam ironing of fabrics as a way of causing reduction of physiological and/or subjective reactivity to stress in humans
12/17/2002	US6495167 Preparation of powder agglomerates
12/17/2002	US6495166 Microencapsulation of risperidones or bupivacaine using glycolic acid-lactic acid copolymers and solvent emulsions to form sustained or time-release agents
12/17/2002	US6495165 Eplerenone compositions having improved bioavailability
12/17/2002	US6495164 Preparation of injectable suspensions having improved injectability
12/17/2002	US6495163 Moisture barrier film coating composition, method and coated form
12/17/2002	US6495162 Controlled release oral tablet having a unitary core
12/17/2002	US6495161 Capsules containing such as islet of langerhans, hepatocytes, lymphocytes used for drugs or medical diagnosis, having strength, permeability, porosity and time release
12/17/2002	US6495160 Biphasic multicomponent pharmaceutical dosage forms containing substances able to modify the partitioning of drugs
12/17/2002	US6495159 Transdermal preparation containing serotonin receptor antagonist
12/17/2002	US6495157 Starage stable suppositories comprising antibiotics in form of drug particles dispersed in fats used for treatment of urogenital disorders
12/17/2002	US6495155 Injectable opioid partial agonist or opioid antagonist microparticle compositions and their use in reducing consumption of abused substances
12/17/2002	US6495154 On demand administration of clomipramine and salts thereof to treat premature ejaculation
12/17/2002	US6495148 High molecular weight polyuronic acids used as moisturizers and for prevention of skin disorders, ulcers, wrinkles, dryness or aging
12/17/2002	US6495131 Adenovirus vector
12/17/2002	US6495124 Compositions are used for the treatment of onychomycosis.
12/17/2002	US6495120 Formulation and system for intra-oral delivery of pharmaceutical agents
12/17/2002	CA2271622C Antiviral agents from plant extracts and use for treatment of viral infections
12/17/2002	CA2225808C Silver-based pharmaceutical compositions
12/17/2002	CA2199053C Composition including a polymeric system and use of the said system
12/17/2002	CA2188688C Use of lanthanide, tin, zinc, manganese, yttrium, cobalt, barium, strontium salt in a skin care composition
12/17/2002	CA2165520C P substance antagonist used in a pharmaceutical composition
12/17/2002	CA2153340C Application of riluzole in the treatment of parkinson's desease and parkinsonian syndromes
12/17/2002	CA2131822C Use of estriol for treating climacteric osteoporosis
12/17/2002	CA2095223C Topical compositions for transdermal delivery of prodrug derivatives of morphine
12/17/2002	CA2083061C Peat-derived bioactive products and pharmaceutical and cosmetic compositions containing them
12/17/2002	CA2069153C Pharmaceutical composition
12/17/2002	CA2068957C Pharmaceutical composition
12/17/2002	CA2063106C Ciclosporin form for pulmonary administration
12/17/2002	CA2062091C Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
12/17/2002	CA2037408C A nonaqueous pharmaceutical macrolide solution
12/17/2002	CA2021570C Polysiloxane-grafted copolymer topical binder composition with novel hydrophilic monomers and method of coating therewith
12/12/2002	WO2002099457A1 Microchip devices with improved reservoir opening
12/12/2002	WO2002099036A2 Inhibition of neurodegeneration
12/12/2002	WO2002099026A1 Methods and formulations for enhancing the dissolution of a solid material in liquid
12/12/2002	WO2002098998A1 System for releasing active substances and active agents
12/12/2002	WO2002098952A1 Lipid-polymer-conjugates compositions
12/12/2002	WO2002098951A2 Lipid-polymer-conjugates
12/12/2002	WO2002098874A2 Inhalation capsules
12/12/2002	WO2002098528A1 Azeotrope-like compositions of pentafluorobutane
12/12/2002	WO2002098515A2 Topical treatments using alkanolamines
12/12/2002	WO2002098505A1 Digestive organ stimulator
12/12/2002	WO2002098496A1 An aerosol forming device for use in inhalation therapy
12/12/2002	WO2002098482A2 System for osmotic delivery of pharmaceutically active agents
12/12/2002	WO2002098477A2 Bioactive surface modifiers for polymers and articles made therefrom
12/12/2002	WO2002098464A2 Liquid polymer composition for prevention and treatment of the oral cavity diseases
12/12/2002	WO2002098459A2 USE OF IgM ANTIBODIES AGAINST dsDNA IN SYSTEMIC LUPUS ERYTHEMATOSUS WITH NEPHRITIS
12/12/2002	WO2002098434A1 Method of producing calcium gluconolactate, compositions, processes and uses of same
12/12/2002	WO2002098413A2 Pharmaceutical compositions comprising orlistat and fatty acids and/or salts thereof
12/12/2002	WO2002098404A1 Topical compositions for veterinary uses
12/12/2002	WO2002098396A1 Percutaneously absorbable patches
12/12/2002	WO2002098395A1 Tts with peel-off film with reduced resistance to tearing
12/12/2002	WO2002098394A1 Method of tablet enrobing
12/12/2002	WO2002098393A1 Tablet coating composition
12/12/2002	WO2002098392A1 Nsaid formulation comprising a granular composition and an extra-granular composition
12/12/2002	WO2002098391A2 Process for preparing granular compositions
12/12/2002	WO2002098390A2 Delivery of aerosols containing small particles through an inhalation route
12/12/2002	WO2002098389A1 Method of forming an aerosol for inhalation delivery
12/12/2002	WO2002098388A2 Effervescent formulations of non-steroidal anti-inflammatory drugs
12/12/2002	WO2002098387A1 Formulation comprising melt granules of nsaids and organic acids
12/12/2002	WO2002098352A2 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs
12/12/2002	WO2002098348A2 Glp-1 formulations with protracted time action
12/12/2002	WO2002098345A1 Use of an antioxidant for treating and/or preventing surface ocular disorders
12/12/2002	WO2002098339A2 Zinc containing compositions for anti-viral use
12/12/2002	WO2002098242A1 Calorically dense liquid oral supplement
12/12/2002	WO2002098226A1 Method for reducing muscle fatigue through administration of adenosine triphosphate
12/12/2002	WO2002098222A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds
12/12/2002	WO2002090313A8 Aloe-emodin derivatives and their use in the treatment of neoplastic pathologies

1 ... 2200 2201 2202 2203 2204 2205 2206 2207 2208 2209 2210 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 ... 2991